186 related articles for article (PubMed ID: 12384163)
21. Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis.
Lein M; Jung K; Elgeti U; Petras T; Stephan C; Brux B; Sinha P; Winkelmann B; Schnorr D; Loening S
Eur Urol; 2001 Jan; 39(1):57-64. PubMed ID: 11173940
[TBL] [Abstract][Full Text] [Related]
22. A multicenter clinical trial on the use of complexed prostate specific antigen in low prostate specific antigen concentrations.
Lein M; Kwiatkowski M; Semjonow A; Luboldt HJ; Hammerer P; Stephan C; Klevecka V; Taymoorian K; Schnorr D; Recker F; Loening SA; Jung K
J Urol; 2003 Oct; 170(4 Pt 1):1175-9. PubMed ID: 14501719
[TBL] [Abstract][Full Text] [Related]
23. Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer?
Jung K; Elgeti U; Lein M; Brux B; Sinha P; Rudolph B; Hauptmann S; Schnorr D; Loening SA
Clin Chem; 2000 Jan; 46(1):55-62. PubMed ID: 10620572
[TBL] [Abstract][Full Text] [Related]
24. Complexed prostate-specific antigen as a staging tool: results based on a multicenter prospective evaluation of complexed prostate-specific antigen in cancer diagnosis.
Taneja SS; Hsu EI; Cheli CD; Walden P; Bartsch G; Horninger W; Babaian RJ; Fritsche HA; Childs S; Stamey TA; Sokoll LJ; Chan DW; Brawer MK; Partin AW; Lepor H
Urology; 2002 Oct; 60(4 Suppl 1):10-7. PubMed ID: 12384157
[TBL] [Abstract][Full Text] [Related]
25. Free and complexed prostate-specific antigen (PSA) in the early detection of prostate cancer.
Tello FL; Prats CH; González MD
Clin Chem Lab Med; 2001 Feb; 39(2):116-20. PubMed ID: 11341744
[TBL] [Abstract][Full Text] [Related]
26. Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
Strittmatter F; Stieber P; Nagel D; Füllhase C; Walther S; Stief CG; Waidelich R
Eur J Med Res; 2011 Oct; 16(10):445-50. PubMed ID: 22024423
[TBL] [Abstract][Full Text] [Related]
27. Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening program.
Barqawi AB; Golden BK; O'Donnell C; Brawer MK; Crawford ED
Urology; 2005 Apr; 65(4):708-12. PubMed ID: 15833513
[TBL] [Abstract][Full Text] [Related]
28. [The application of complexed PSA and its relative indexes in the diagnosis of prostate cancer].
Chen ZH; Zhao J; Wu JM; Xiao CG
Zhonghua Nan Ke Xue; 2003 Feb; 9(1):36-9. PubMed ID: 12680329
[TBL] [Abstract][Full Text] [Related]
29. Comparative evaluation of various prostate specific antigen ratios for the early detection of prostate cancer.
Ozdal OL; Aprikian AG; Bégin LR; Behlouli H; Tanguay S
BJU Int; 2004 May; 93(7):970-4; discussion 974. PubMed ID: 15142145
[TBL] [Abstract][Full Text] [Related]
30. New insights into the diagnostic accuracy of complexed and total prostate specific antigen using discordance analysis characteristics.
Jung K; Lein M; Butz H; Stephan C; Loening SA; Keller T
J Urol; 2006 Apr; 175(4):1275-80. PubMed ID: 16515979
[TBL] [Abstract][Full Text] [Related]
31. Free/total PSA ratio improves differentiation of benign and malignant disease of the prostate: critical analysis of two different test populations.
Veltri RW; Miller MC
Urology; 1999 Apr; 53(4):736-45. PubMed ID: 10197849
[TBL] [Abstract][Full Text] [Related]
32. Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancer.
Naya Y; Fritsche HA; Cheli CD; Stamey TA; Bartsch G; Brawer MK; Childs S; Taneja SS; Lepor H; Partin AW; Sokoll LJ; Chan DW; Babaian RJ
Urology; 2003 Dec; 62(6):1058-62. PubMed ID: 14665355
[TBL] [Abstract][Full Text] [Related]
33. [Diagnostic value of complexed prostate-specific antigen for prostate cancer].
Su HW; Li Y; Xu P
Zhonghua Nan Ke Xue; 2003 Sep; 9(6):431-3. PubMed ID: 14574807
[TBL] [Abstract][Full Text] [Related]
34. Complexed prostate specific antigen: better test in the diagnosis of prostate cancer for the clinically relevant 2.5-4 ng/ml total PSA range.
Mutlu N; Türkeri LN; Yencilek F; Demir A; Emerk K
Can J Urol; 2009 Apr; 16(2):4558-67. PubMed ID: 19364428
[TBL] [Abstract][Full Text] [Related]
35. Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen <4 microg/L: are they useful tools for early detection and screening of prostate cancer?
Jung K; Stephan C; Elgeti U; Lein M; Brux B; Kristiansen G; Rudolph B; Hauptmann S; Schnorr D; Loening SA; Sinha P
Int J Cancer; 2001 Sep; 93(5):759-65. PubMed ID: 11477592
[TBL] [Abstract][Full Text] [Related]
36. Complexed prostate-specific antigen and its volume indexes in the detection of prostate cancer.
Maeda H; Arai Y; Aoki Y; Okubo K; Okada T; Maekawa S
Urology; 1999 Aug; 54(2):225-8. PubMed ID: 10443715
[TBL] [Abstract][Full Text] [Related]
37. The measurement of complexed prostate-specific antigen has a better performance than total prostate-specific antigen.
Herrmann W; Stöckle M; Sand-Hill M; Hübner U; Herrmann M; Obeid R; Wullich B; Loch T; Geisel J
Clin Chem Lab Med; 2004; 42(9):1051-7. PubMed ID: 15497472
[TBL] [Abstract][Full Text] [Related]
38. Similar age-specific PSA, complexed PSA, and percent cPSA levels among African-American and white men of southern Louisiana. Prostate-specific antigen.
Martin B; Cheli C; Pollard S; Sullivan J; Goodman J; Kokatnur M; Ward M; Martin L; Mercante D; Rayford W
Urology; 2003 Feb; 61(2):375-9. PubMed ID: 12597951
[TBL] [Abstract][Full Text] [Related]
39. Complexed and total PSA in patients with benign prostatic hyperplasia and prostate cancer.
Tamimi W; Dafterdar R; Mansi M; Alsaad K; Alarifi SA
Br J Biomed Sci; 2010; 67(4):184-8. PubMed ID: 21294445
[TBL] [Abstract][Full Text] [Related]
40. Comparison of several combinations of free, complexed, and total PSA in the diagnosis of prostate cancer in patients with urologic symptoms.
Filella X; Truan D; Alcover J; Quintó L; Molina R; Luque P; Coca F; Ballesta AM
Urology; 2004 Jun; 63(6):1100-3; discussion 1103-4. PubMed ID: 15183958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
